AEON Biopharma, Inc. earnings per share and revenue
On 14 de nov. de 2025, AEON reported earnings of -0.19 USD per share (EPS) for Q3 25, beating the estimate of -0.43 USD, resulting in a 56.68% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.77% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were AEON Biopharma, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, AEON Biopharma, Inc. reported EPS of -$0.19, beating estimates by 56.68%, and revenue of $0.00, 0% as expectations.
How did the market react to AEON Biopharma, Inc.'s Q3 2025 earnings?
The stock price moved down -3.77%, changed from $0.94 before the earnings release to $0.90 the day after.
When is AEON Biopharma, Inc. expected to report next?
The next earning report is scheduled for --.
What are the forecasts for AEON Biopharma, Inc.'s next earnings report?
Based on --
analistas, AEON Biopharma, Inc. is expected to report EPS of -- and revenue of -- for Q-- --.